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Host inflammatory mediators, such as interferons, play a protective role in infection, but the mechanism is undefined
and may differ between tissue compartments. To determine whether interferon-g (IFN-g) elicitation prevents destructive
encephalitis in herpes simplex virus type 1 (HSV-1) infection of the central nervous system, IFN-g-knockout (GKO) mice
were challenged intravitreally with HSV-1 strain F, inciting infection of the eyes and the brain. Indeed, the GKO mice showed
encephalitis with ataxia, whereas nontransgenic controls remained asymptomatic. Morphology and digoxigenin labeling of
DNA fragments revealed increased apoptosis in the brains of GKO mice compared with controls, although viral replication
was not influenced at early stages of infection. Greater numbers of apoptotic cells in the brains of GKO mice correlated
with neurological symptoms, as well as lower expression of the protective protooncogene bcl-2. Thus, IFN-g inhibits
apoptosis, affording neuronal protection from destructive encephalitis during viral infection of the central nervous system.
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expression (Borysiewicz and Sisson, 1994; Chou andINTRODUCTION
Roizman, 1992).
To test the hypothesis that cytokine production pro-Interferon-g (IFN-g) induces cellular inflammation and
tects neurons in the CNS from cell death, we injectedpossesses distinct antiviral properties (Di Fabio et al.,
HSV-1 into mice deficient in IFN-g production. These1994; Hendricks et al., 1992; Sandberg et al., 1994;
IFN-g knockout (GKO) mice were characterized with re-Schijns et al., 1994). Earlier, these properties were as-
spect to the occurrence of apoptosis in response to HSVcribed to inhibition of viral replication (Karupiah et al.,
infection. We also correlated apoptosis with neurological1993). However, recent studies have shown that several
symptoms in infected mice and analyzed expression ofviruses of the herpes family, including multiple herpes
the apoptosis-related proteins Bcl-2, Bcl-x, and Bax (Da-simplex virus type 1 (HSV-1) strains, are only marginally
vies, 1995; Nunez et al., 1994; Zhong et al., 1993) andsensitive to the inhibitory effects of cytokines on their
inducible nitric oxide synthase (iNOS) (Mannick et al.,replication (Geiger et al., 1994b, 1995; Graziosi et al.,
1994; Messmer et al., 1994).1994). For example, IFN-g produced only in the eyes
of HSV-1-infected transgenic mice protected them from
MATERIALS AND METHODSencephalitis following intraocular inoculation without in-
fluencing replication of the virus in the central nervous Animals
system (CNS) (Geiger et al., 1994b). This cytokine-medi-
We used C57BL/6-derived IFN-g-deficient GKO trans-ated neuronal protection was associated with increased
genic mice (Dalton et al., 1993) and nontransgenic lit-expression of Bcl-2 and inhibition of apoptosis in the
termates (controls) between 6 and 8 weeks of age. Fivebrain (Geiger et al., 1995). The apoptosis-suppressing
or six age-matched animals were used per group andactivities of IFN-g may be indirect, stemming from ac-
time point. Animals had no ocular abnormalities andtions of other secondary factors or abrogation of the CNS
were routinely screened for the homologous insertionimmune privilege (Pollak and Lund, 1990; Sloan et al.,
using polymerase chain reaction (PCR) amplification of1991), alteration of T-cell activation patterns, or viral gene
tail DNA (Dalton et al., 1993).
Virus and infection protocol1 Scripps manuscript 10233-NP.
2 Present address: Neurologisches Institut, University of Frankfurt,
HSV-1 strain F (Roizman et al., 1972) was grown onDeutschordenstrasse 46, D-60528 Frankfurt, Germany.
Vero cells, titrated and plaque purified as described pre-3 To whom reprint requests should be addressed. Fax: (619) 784-
9083. E-mail: noras@scripps.edu. viously (Cooper, 1967). Inocula of I ml, containing 2 1 105
189
0042-6822/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID VY 8841 / 6a53$$$361 10-24-97 11:13:12 viras AP: VY
190 GEIGER ET AL.
PFU HSV-1, were injected into the vitreous of the right counted in sections from similar anatomical locations, at
a magnification of 201 in the light microscope equippedeye, and control animals were mock-infected with phos-
phate-buffered saline (PBS) (Geiger et al., 1994b). In- with a graded ocular lens (10 squares, 50 1 50 mm each)
(C. Zeiss).fected mice were monitored daily for signs of disease,
and neurological symptoms were scored for severity on a
Recovery of infectious virusscale of 1–4 points. Scoring criteria comprised abnormal
behavior and movement, including abnormal stretching, To recover and quantitate infectious virus, we homoge-
capacity of limb usage (grabbing of small objects such as nized tissues of eyes and brains from six mice per group
Q-tips), and seizures as observed visually. Additionally, in total. Two or five eyes or brains per group were homog-
coordinated movement was assessed by the capacity to enized for 15 s using a mechanical homogenizer (Ultra-
move on inverted grids and to balance on 10-ml cell Turrax, IKA) in 800 (1000) or 5000 (2005) ml phosphate-
culture pipets (Falcon) for more than 1 min (three at- buffered saline (PBS) or Dulbecco’s modified Eagle
tempts). Scoring points were distributed according to the Medium (DMEM), respectively. Plaque assays were per-
following criteria: 0 points  no neurological symptoms; formed and quantitated as previously described (Cooper,
1 point  abnormal stretching, no movement disorder, 1967; Geiger et al., 1995).
no impairment of coordination or limb usage; 2 points 
slight movement disorder visible, no impairment of limb In situ hybridization
usage, slight impairment of movement coordination (30 –
Expression of IFN-g mRNA in brain tissue was studied60 s on inverted grid or pipet); 3 points ataxia, impaired
by in situ hybridization. Paraffin-embedded sections werelimb usage with mostly asymmetrically diminished ca-
deparaffinized and prehybridized for 4 h at 427C in apacity to grab small objects, severe disturbance of move-
buffer consisting of 50% formamide, 0.3 M NaCl, 20 mMment coordination (falls from inverted grid, unable to bal-
Tris, pH 8.0, 5 mM EDTA, 11 Denhardt’s solution, 10%ance on pipet); 4 points  paralysis, seizures, no further
dextran sulfate, and 10 mM dithiothreitol. Hybridizationtesting possible. Histological analysis was performed as
was performed for 24 h at 427C in a humidified chamber,previously described (Geiger et al., 1995). PCR was used
using 35S-labeled antisense and sense RNA probes ofto study the presence of the viral genome in mice without
the IFN-g gene. Sections were dipped in Kodak NTB2expression of HSV antigen. Twenty-five-micrometer-thick
emulsion and developed after 1–3 weeks (Geiger et al.,paraffin-embedded sections were deparaffinized, dehy-
1994b).drated, and treated with proteinase K (Sigma) 4 mg/ml
for 14 h at 567. PCR was performed using a set of two
RESULTSprimers encoding HSV-1 DNA polymerase (Genzyme/
Dunn, Asbach, Germany) following the recommendations
To test the hypothesis that IFN-g production regulatesof the manufacturer.
neuronal protection in HSV-1 infection of the CNS, we
assessed disease pathogenesis in intravitreally infectedHistology and immunochemistry
GKO mice and control animals. We also studied the eyes
Primary antibodies were polyclonal HSV-1; monoclonal and brains of these animals for histopathology, inflamma-
MAC-1 (Boehringer-Mannheim); monoclonal Ly-2 (anti- tion, viral antigen, and viral titers. In situ hybridization
CD8) and L3T4 (anti CD4) (Pharmingen); monoclonal F4/ was used to demonstrate IFN-g mRNA production in the
80 (Serotec); and macrophage-generated iNOS (Trans- brains of infected normal mice. In search of potential
duction Laboratories). Polyclonal anti-mouse Bcl-x (Kraw- mechanisms influencing the course of disease in the
jewski et al., 1994b) and Bcl-2 and Bax (Krajewski et CNS, we looked for indicators of apoptosis and for ex-
al., 1994a) were used on paraffin-embedded sections. pression of antigens related to the development of
Interleukin-4 (IL-4) was assessed using an IL-4-sandwich apoptosis such as Bcl-2, Bcl-x, and Bax. Additionally, by
ELISA kit (Pharmingen), as recommended by the manu- ELISA for IL-4, we searched for evidence of preferential
facturer. Development followed in an extraavidin–p-ni- establishment of a Th2-like environment in the brains of
trophenol phosphate disodium (pNPP) system Sigma). IFN-g-deficient GKO mice that may influence the out-
come of disease.
Apoptosis
Encephalitis and prolonged expression of viral
Apoptosis was assessed on paraffin-embedded tissue antigen in GKO mice
using the ApopTag Kit (Oncor); enzymatic in situ labeling
of fragmented 3*-OH DNA ends was done with digoxi- All mice injected with HSV-1 strain F survived. Non-
transgenic control mice were only slightly lethargic be-genin–UDP and an anti-digoxigenin peroxidase second-
ary antibody. Positively stained sections were evaluated tween Days 5 and 8 after infection, whereas GKO mice
became sick by Days 4–5, displaying a rough coat, ab-in comparison to morphological findings. Cells were
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normal stretching, and ataxia and reduced capacity for Mock-infected mice showed no morphological or cellular
changes.limb usage and coordinated movement. The GKO mice
displayed increased severity in clinical symptoms com-
IFN-g does not influence replication of HSV-1pared with control mice during the entire 14-day observa-
tion period; most control mice appeared normal by Day To assess possible effects of a systemic lack of IFN-
14, whereas all of the GKO mice retained symptoms of
g on viral replication, plaque assays were performed to
infection at this time point. quantitate infectious virus in tissues of infected mice. By
Pathology was visible at Days 4–5, when retinitis 24 h after viral inoculation, the right eyes of GKO mice
started in the right, virus-injected eye of both control and as well as nontransgenic recipients yielded similar
GKO mice, then progressed to the brain and the left eye amounts of infectious virus. At 4–10 days the brains and
by Days 5–6. Viral antigen was detectable when in the left eyes yielded small amounts of infectious virus with-
eyes and the brains (Fig. 1a) of all inoculated mice, as out significant difference between the two groups (Fig.
was cellular infiltration consisting of macrophages, natu- 3). Only in the right eyes of infected GKO mice was a
ral killer cells, and lymphocytes. However, at Day 5 after slight increase in infectious virus above the values of
infection, GKO mice appeared to have slightly larger control mice visible by Day 6.
numbers of viral antigen-positive cells in their eyes and
brains than controls. These antigen-positive cells con- Cytokine production in brains infected with HSV-1
sisted mainly of neurons, some glial cells, and macro-
With in situ hybridization using a probe for IFN-gphages. In the eyes, infected neurons were situated
mRNA, single cells producing IFN-g were detected inmostly in the ganglion cell layer and the photoreceptor
the brains of nontransgenic mice (Fig. 1d), but not GKOlayer. The brains contained antigen-positive neurons in
mice. By 10 days after infection, these cells were presentthe suprachiasmatic nucleus, the geniculate, and the oc-
in areas containing cellular infiltrates. As evaluated mor-cipital cortex. In control mice, the number of HSV antigen-
phologically, these cells consisted of T lymphocytes andpositive cells was similar at Days 5 and 10; however, in
larger, macrophage-like cells presumably originating inGKO mice the number of positive cells doubled between
the bloodstream. ELISA for IL-4 was performed on brainDays 5 and 10 (data not shown). Thus, the control mice
extracts to find out whether the lack of IFN-g may favordid not clear the infection but were comparatively better
the development of a Th-2 environment in the CNS afterat controlling it, but in GKO mice the infection pro-
infection with HSV-1. However, screening for IL-4 yieldedgressed. However, by 18 days after infection, no viral
no measurable quantities of this cytokine in the eyes orantigen was visible in either group, although HSV-1 ge-
brains of either group (data not shown).nome was detectable by PCR in eyes and brains of both
GKO and control mice.
Increased numbers of apoptotic cells in the brains of
GKO miceInflammatory changes in eyes and brains after
infection with HSV-1 In search of mechanisms responsible for the increased
neurological symptoms of IFN-g-deficient GKO mice, we
At Day 10 after infection, inflammatory infiltrates con- labeled DNA fragments of cells undergoing apoptosis en-
sisted mainly of macrophages and lymphocytes, includ- zymatically with digoxigenin–UDP [TUNEL technique
ing CD4/ and CD8/ cells, as demonstrated by immuno- (Cantin et al., 1995)] for detection with an anti-digoxigenin
cytochemistry (Table 1). GKO mice had fewer macro- peroxidase system. Clearly, more cells were undergoing
phages in their brains than nontransgenic mice, slightly apoptosis in brains of GKO mice than in those of their
fewer CD4/ and CD8/ cells in their left, uninoculated nontransgenic littermates (Fig. 4). Morphologically, apo-
eyes, and smaller numbers of ocular cells positive for ptotic cells consisted mostly of neurons as well as some
macrophage-generated iNOS (Fig. 2). iNOS-positive cells astrocytes, macrophages, and small cells, probably infil-
that were present appeared in the iris, the retinal pigment trating lymphocytes (Fig. 1g). Additionally, there was a
epithelium layer, the photoreceptor layer, and the gan- relative increase in expression of Bcl-2 on neurons of the
glion cell layer of the retina. Additional positive cells were brains of nontransgenic mice infected with HSV-1 (Figs.
found in the vitreous (Fig. 1c). Cells of the retinal pigment 1e, 1f). Expression of Bcl-x and Bax was high in the brains
epithelium (Cooper, 1967) did not react with the iNOS of both groups and indistinguishable between transgenic
antibody used, nor did astrocytes in normal noninfected and nontransgenic mice (not shown).
brains. Although the brains of GKO mice showed only
small numbers of cells expressing iNOS, brains of the DISCUSSION
controls had noticeable numbers of iNOS-positive cells,
mainly in areas containing viral antigen, around the ven- To study the effect of systemic IFN-g production on
viral infection of the CNS, we compared GKO transgenictricle system and in the choroid plexus (Fig. 1c, Table 1).
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mice, which are unable to produce IFN-g, with their non-
transgenic counterparts after injection of HSV-1 strain F
into the vitreous humor chamber of the right eyes. All
animals became infected, and virus spread to the contra-
lateral eye via the optic nerve and the optic chiasm. The
host responded with inflammatory responses in both
eyes and the brain. Production of IFN-g was not neces-
sary for survival; however, mice without IFN-g suffered
from encephalitis, manifested by ataxia, whereas the
IFN-g-expressing nontransgenic controls did not. Al-
though mice of both groups successfully restricted viral
spread and eliminated virus, the GKO mice took longer
to clear active infection. Additionally, greater numbers of
apoptotic cells were found in the brains of GKO mice,
corresponding to more severe encephalitis and reduced
expression of Bcl-2 compared with controls.
Additional differences between GKO mice and these
controls included smaller numbers of iNOS/ macrophages
in the brains of GKO mice and a slightly lower content of
CD4/ and CD8/ T cells in their left, uninjected eyes. The
capacity to produce IFN-g did not inhibit early stages of
viral replication in eyes or brains of infected mice, although
viral antigen was detectable for a longer period in GKO
mice. Initially, this phenomenon was interpreted as persis-
tence of active infection (Bouley et al., 1995). However, the
extended study done here showed that GKO mice were
capable of clearing active infection, albeit after a longer
interval than controls. Neither group of mice was able to
clear viral genomes from the CNS. It is possible that a
FIG. 1. Morphology of eyes and brains after infection with HSV-
1. (a) Detail of the brain of a normal mouse Day 6 after infection.
Immunostaining for HSV antigen reveals viral antigen present in the
suprachiasmatic area. Paraffin-embedded section, indirect immunoper-
oxidase method, DAB/hematoxylin. Light microscopic magnification
136. (b) Detail of the brain of a GKO mouse Day 10 after infection.
Gray matter of the occipital cortex contains shrunken neurons with
oddly shaped fragmented nuclei, displaying features of apoptosis. Par-
affin-embedded section, H&E. Light microscopic magnification 190,
1100, oil immersion. (c) Immunostaining for iNOS in the brain of a
GKO mouse Day 6 after infection reveals brown positive cells in areas
surrounding the ventricle system. Paraffin-embedded section, indirect
immunoperoxidase method, DAB/hematoxylin. Light microscopic mag-
nification118. (d) In situ hybridization for IFN-g in the brain of a normal
mouse Day 10 after infection. Paraffin-embedded section, autoradiogra-
phy with 35S-labeled probe, using Kodak NTB-developing system, coun-
terstaining with hematoxylin. Light microscopic magnification 136. (e)
Immunostaining for Bcl-2 in the brain of a GKO mouse Day 10 after
infection reveals positive staining of neurons in the suprachiasmatic
area. Paraffin-embedded section, indirect immunoperoxidase method,
DAB/hematoxylin. Light microscopic magnification 136. (f) Immuno-
staining for Bcl-2 in the brain of a normal mouse Day 10 after infection
reveals positive staining of neurons. Paraffin-embedded section, indi-
rect immunoperoxidase method, DAB/hematoxylin. Light microscopic
magnification 136. (g) Staining for apoptosis in the brain of a GKO
mouse Day 10 after infection using DNA tailing with digoxigenin-labeled
dUDP. Indirect immunoperoxidase method DAB/hematoxylin. Light mi-
croscopic magnification 136.
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TABLE 1
Immunostaining in Control Mice and Interferon-Deficient GKO Mice after Infection with HSV-1 Strain F
Mice/days MAC-1
after infection Organ HSV-1a CD4 CD8 F4/80 iNOSb Bcl-2 Bcl-x Bax
Control/5 Right eye /// // / / /// Ø Ø Ø
Left eye (/) 0 0 0 (/) Ø Ø Ø
Brain // (/) 0 0 (/) /// /// ///
GKO/5 Right eye /// // (/) (/) / Ø Ø Ø
Left eye (/) 0 0 0 (/) Ø Ø Ø
Brain // / 0 0 (/) / /// ///
Control/10 Right eye /// /// // / /// Ø Ø Ø
Left eye // // / (/) /// Ø Ø Ø
Brain // / / (/) / /// /// ///
GKO/10 Right eye /// /// // (/) / Ø Ø Ø
Left eye // (/) 0 0 (/) Ø Ø Ø
Brain // / / 0 / / /// ///
Control/18 Right eye 0 Ø Ø Ø / Ø Ø Ø
Left eye 0 Ø Ø Ø (/) Ø Ø Ø
Brain 0 Ø Ø Ø / / /// ///
GKO/18 Right eye 0 Ø Ø Ø / Ø Ø Ø
Left eye 0 Ø Ø Ø (/) Ø Ø Ø
Brain 0 Ø Ø Ø / / /// ///
a Positive cells were counted in anatomically similar locations, checking different areas with a graded ocular (10 squares, 50 1 50 mm each).
Average values were used as follows: 0, no positive cells; (/), single cell/square; /, 2–5 cells/square; //, 6–10 cells/square; ///, more than
10 cells/square; Ø, not counted.
b Normal staining for iNOS within the retinal pigment epithelium, or staining comparable to values in noninfected controls, was disregarded.
relatively subtle increase in HSV virus replication due to tion of active infection in the CNS. Therefore, by influenc-
ing the local environment of the CNS, IFN-g may drivethe lack of IFN-g could be responsible for the increased
cell death observed in GKO mice. Our assay of viral titer viral infection into latency and possibly participate in the
regulation of latency and reactivation as suggested ear-would not be able to detect subtle (twofold) statistically
significant differences in viral replication. lier (Geiger et al., 1995). However, this phenomenon ap-
parently depends not entirely on local cytokine produc-Our results point toward a connection between the
production of IFN-g in response to viral infection and the tion but also requires systemic IFN-g, since IFN-g made
in the brain most likely arises from infiltrating cells (Tyoroccurrence of neurological symptoms. Apparently, the
mechanism is not a direct effect of the cytokine (Karupiah et al., 1992), which produce the cytokine in response to
viral antigen (Geiger et al., 1995) as confirmed by our inet al., 1993; Mueller et al., 1994; Schijns et al., 1994),
since the presence of IFN-g did not alter viral replication. situ findings. Thus, the occurrence of apoptosis following
viral infection does not curtail the replication and spreadIn fact, the increased apoptosis in the brains of GKO
mice may have been at least partially responsible for the of the HSV virus, but is detrimental to the health of the
host, presumably because of the loss of neurons. Thedevelopment of neurological symptoms after infection
spread to the CNS. We have recently demonstrated that observation of cell death by apoptosis is shared with
several viruses (Tsunoda et al., 1997; Oberhaus et al.,expression of IFN-g in the retinas of transgenic mice
diminishes the extent of apoptosis in their brains after 1997; Lewis et al., 1996; Jackson and Rositer, 1997).
The heightened apoptosis in the absence of IFN-ginfection with HSV-1 and HSV-2 (Geiger et al., 1995). The
present study confirmed those data and suggested that observed here could be related to the lack of upregula-
tion of Bcl-2, which apparently was not accompanied byapoptosis accompanying herpes infection of the CNS
was indeed influenced by IFN-g, possibly by indirect changes in the expression of Bcl-x or Bax. All three pro-
teins have been linked to the regulation of apoptosismechanisms. That is, IFN-g might have either induced
the action of other cytokines or altered viral gene expres- and can bind to each other, presumably as heterodimers
(Allsopp et al., 1993; Behl et al., 1993; Hanada et al., 1993;sion and infectious properties. Additionally, the present
data suggest that the maintenance of active infection Oltvai et al., 1993; Yin et al., 1994; Miyashita et al., 1994).
Bcl-2, which is expressed at low levels in the adult brain,may have a role in the development of neuronal damage.
The persistence of viral antigen for a longer time in the participates in the related developmental regulation of
apoptosis (Abe-Domae et al., 1993; Griffin et al., 1994).brains of GKO mice implies that IFN-g affected the dura-
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et al., 1995). Bcl-x knockout mice are not viable, presum-
ably because of massive neuronal apoptosis (Motoyama
et al., 1995). In contrast, Bax has been related to the
induction of apoptosis (Miyashita et al., 1994). Expression
of Bax is elevated in neurons undergoing apoptosis in
response to hypoxemia (Bredesen, 1995). Regulatory
mechanisms could lie in the relative expression levels
of the counterregulatory proteins (Oltvai et al., 1993). The
present findings indicate that a cytokine-induced shift in
the balance between apoptosis and cellular survival was
influenced by Bcl-2 but not Bcl-x. Similar relations be-
tween IFN-g, Bcl-2, and apoptosis were reported earlier
in myeloid cells (Lotem and Sachs, 1995).
Interestingly, the differences we observed in the num-
bers of T cells in infected GKO and nontransgenic mice
were restricted mostly to their left, uninoculated eyes,
confirming that a systemic cellular immune response
FIG. 2. Inducible NO synthetase (iNOS) in the brains of mice infected was involved in the development of retinitis in that eye
with HSV-1. Immunostaining for iNOS on paraffin-embedded sections, (Lotem and Sachs, 1995; Whittum-Hudson and Pepose,
indirect immunoperoxidase method, DAB/hematoxylin. Light micro- 1987). Because of the immunological sequestration of
scopic original magnification 120. Positive cells were counted in ana-
the eye (Rocha and Baines, 1992; Streilein, 1990, 1993;tomically similar locations, checking different areas with a graded ocu-
Tompsett et al., 1990), an effective response to intraocu-lar (10 squares, 50 1 50 mm each). Cells were counted in six brains
or eyes. Error bars represent the standard deviation of the organs of lar viral infection requires breakdown of the blood –retina
one group. r  right eye, l  left eye, br  brain. barrier before induction of the cellular immune response
(Streilein, 1993). The intraocular immune privilege may
have been responsible for delayed activation of the sys-
temic immune response, namely, the activation of T cells.Moreover, the activity of this protein can be mimicked or
In turn, T-cell activation should be less effective in miceinfluenced by several viruses (Akbar et al., 1994; Hender-
that cannot produce IFN-g (Dalton et al., 1993; Ho et al.,son et al., 1991; Rabizadeh et al., 1993; Ubol et al., 1994;
1988). Since the blood–tissue barrier is permissive forYamada et al., 1994; Zauli et al., 1993). Although the
activated T cells (Ksander and Streilein, 1989, 1990), cellfunction of Bcl-x in the brain is not yet fully known, this
counts for CD4/ and CD8/ cells in eyes and brains giveprotein is expressed at high levels in the adult brain and
indirect information about T-cell activation but do notit has been linked to the inhibition of apoptosis in growth
factor-dependent neurons (Boise et al., 1993; Frankowski measure their function.
FIG. 3. Recovery of infectious virus from brains of infected mice. (A) Recovery of infectious virus from inoculated right eyes of GKO and control
mice. (B) Recovery of infectious virus from brains of infected GKO and control mice. Plaque assay was performed (see Materials and Methods) on
Vero cells using homogenates of six organs per group. Error bars represent the standard deviation of each group calculated from at least two
experiments.
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Some relationship between IFN-g and the quantity of
apoptosis in neurons of the brain is very likely, although
still speculative. The mechanisms by which IFN-g inhibits
apoptosis are likely to be indirect, possibly linked to cyto-
kine influence on the maintenance of active infection. The
concept that an entire system of components governs
apoptosis suggests that IFN-g participates in its induction
among brain cells, as formerly observed among leukocytes
(Colotta et al., 1992; Novelli et al., 1994). However, the fact
that IFN-g-deficient mice survived CNS infection with HSV-
1 points toward the involvement of additional undefined
factors, possibly compensating for the lack of IFN-g. It is
FIG. 4. Apoptosis in the brains of mice infected with HSV-1. Staining likely that the lack of IFN-g does not preclude the develop-
for apoptosis using DNA tailing with digoxigenin-labeled dUDP (Apop- ment of a Th-1 environment (Mosmann and Coffman, 1989)
toag, ONCOR), indirect immunoperoxidase method, DAB/hematoxylin. in response to infection with HSV-1, a notion that is rein-Light microscopic original magnification 1200. Positive cells were
forced by the lack of IL-4 production in either GKO micecounted in anatomically similar locations using a graded ocular (10
or their nontransgenic counterparts.squares, 50 1 50 mm each). Cells were counted in six brains or eyes,
respectively. Error bars represent the standard deviation of the organs The infection- and damage-limiting activities of the
of one group. cytokine IFN-g in the CNS noted here may have some
therapeutic value in the management of life-threatening
viral encephalopathy, despite the risk of increased cel-
lular infiltration and viral escape from immunologicalThe total numbers of macrophages were slightly
smaller in both the eyes and the brains of GKO mice, as surveillance.
compared with controls, reflecting the known role of IFN-
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